Related Experiment Video
Updated: Jun 4, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Methodology for Safe and Secure AI in Diabetes Management
Remco Jan Geukes Foppen1, Vincenzo Gioia2, Shreya Gupta3
1Independent, Anzio, Italy.
Artificial intelligence (AI) in diabetes management offers personalized care but faces safety and security challenges. Explainable AI (xAI) is crucial for secure, compliant, and trustworthy AI-driven diabetes solutions.
Area of Science:
- Medical Informatics
- Artificial Intelligence
- Diabetes Technology
Background:
- Artificial intelligence (AI) shows promise for enhancing diabetes management through improved monitoring and personalized therapies.
- Clinical integration of AI in diabetes care presents significant challenges concerning patient data safety, security, and regulatory compliance.
- Potential direct impacts on patient health necessitate careful consideration of AI system design and implementation.
Purpose of the Study:
- To provide guidance for developers and researchers on addressing safety, security, and compliance challenges in AI systems for diabetes management.
- To highlight the critical role of explainable AI (xAI) in ensuring security, compliance, and user trust for AI-driven diabetes solutions.
- To examine both technical and regulatory aspects crucial for developing trustworthy and effective explainable AI applications in diabetes care.
Main Methods:
- Analyzing the AI system lifecycle to integrate xAI frameworks, security measures, and risk mitigation strategies.
- Examining technical methodologies for constructing xAI systems throughout the AI development process.
- Reviewing regulatory frameworks, including Governance, Risk, and Compliance (GRC) standards from bodies like the FDA, for AI-enabled healthcare applications.
Main Results:
- Understanding the AI system lifecycle is key to building robust xAI frameworks that address security and mitigate risks.
- Regulatory analysis identifies essential GRC standards for ensuring the safety, efficacy, and ethical integrity of AI in diabetes care.
- Integrating technical and regulatory insights provides a pathway for developing trustworthy AI solutions.
Conclusions:
- Explainable AI (xAI) is foundational for secure, compliant, and trustworthy AI in diabetes management, enhancing clinical decision-making.
- Addressing both technical development and regulatory requirements is essential for safe and effective AI-enabled diabetes care.
- Actionable insights are provided to foster patient engagement and improve clinical outcomes through reliable AI solutions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

